Holen Sie sich die Stockscreener-App
129.50
1.16%
1.48
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Published on: 2025-09-06 04:29:55 - Newser
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $771k in stock - Investing.com Australia
Will Jazz Pharmaceuticals plc be affected by tariffs2025 Technical Overview & Daily Momentum Trading Reports - خودرو بانک
Building trade automation scripts for Jazz Pharmaceuticals plcJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Jazz Pharmaceuticals (JAZZ) Sings License with Saniona for SAN2355 - MSN
Risk vs reward if holding onto Jazz Pharmaceuticals plcInflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Comparing Jazz Pharmaceuticals plc in custom built stock radarsGold Moves & High Accuracy Trade Alerts - Newser
Will Jazz Pharmaceuticals plc rebound enough to break evenWeekly Trend Recap & Fast Entry Momentum Alerts - Newser
Predicting Jazz Pharmaceuticals plc trend using moving averagesTrade Entry Report & Smart Money Movement Tracker - Newser
Will Jazz Pharmaceuticals plc bounce back from current supportEarnings Growth Summary & Daily Technical Forecast Reports - Newser
Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC - GuruFocus
Is Jazz Pharmaceuticals plc a potential multi baggerJuly 2025 Big Picture & High Accuracy Investment Signals - خودرو بانک
Jazz Pharmaceuticals (JAZZ) Price Target Raised After Modeyso Commercial Strategy Update - MSN
Jazz Pharmaceuticals Insider Selling: Signal of Concern or a Strategic Move? - AInvest
Evaluating Jazz Pharmaceuticals plc with trendline analysisJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Will Jazz Pharmaceuticals plc price bounce be sustainable2025 Investor Takeaways & Short-Term Trading Alerts - Newser
Pattern recognition hints at Jazz Pharmaceuticals plc upside2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
What technical models suggest about Jazz Pharmaceuticals plc’s comebackAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
How to use Fibonacci retracement on Jazz Pharmaceuticals plcMarket Activity Report & Advanced Swing Trade Entry Plans - Newser
Transcript : Jazz Pharmaceuticals plc Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 09 - MarketScreener
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN
Can Jazz Pharmaceuticals plc weather a recessionQuarterly Trade Review & AI Enhanced Market Trend Forecasts - خودرو بانک
Custom strategy builders for tracking Jazz Pharmaceuticals plcQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Needham & Company LLC Reiterates "Buy" Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc recovery potential after sell offMarket Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
What recovery options are there for Jazz Pharmaceuticals plc2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
Measuring Jazz Pharmaceuticals plc’s beta against major indicesGap Down & Weekly Market Pulse Alerts - Newser
Can Jazz Pharmaceuticals plc recover in the next quarterMarket Growth Summary & Scalable Portfolio Growth Methods - Newser
What the charts say about Jazz Pharmaceuticals plc todayJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-09-02 10:41:13 - Newser
Should you avoid Jazz Pharmaceuticals plc stock right nowWeekly Market Summary & Reliable Price Action Trade Plans - خودرو بانک
Analyzing recovery setups for Jazz Pharmaceuticals plc investorsWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Published on: 2025-09-01 16:22:28 - beatles.ru
Top chart patterns to watch in Jazz Pharmaceuticals plcJuly 2025 Update & Expert Curated Trade Ideas - Newser
Strategies to average down on Jazz Pharmaceuticals plcVolume Spike & Fast Moving Stock Watchlists - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):